Analysis of changes in the relative mRNA levels of VCP in patients with “predicted” PD and in treated and untreated patients (at stages 1 and 2 of the Hoehn–Yahr scale) and also for Vcp in the peripheral blood of mice used as models of PD revealed significant and specific decreases in expression levels. Here, VCP is linked to Parkinson disease.